Rani Therapeutics Holdings (RANI) Other Working Capital Changes (2020 - 2026)

Rani Therapeutics Holdings' (RANI) quarterly Other Working Capital Changes came in at -$477000.0 in Q1 2026, little changed year-on-year from -$476004.2 in Q1 2025, and up 1.24% quarter-over-quarter from -$483000.0 in Q4 2025.

Rani Therapeutics Holdings (RANI) Other Working Capital Changes (2020 - 2026) Analysis & Trends

Rani Therapeutics Holdings' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$477000.0 for Q1 2026.

  • On a quarterly basis, Other Working Capital Changes changed 0.21% year-over-year to -$477000.0 in Q1 2026; TTM through Mar 2026 was -$1.9 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at -$1.9 million, down 5.59% from the prior year.
  • Other Working Capital Changes advanced to -$477000.0 in Q1 2026 per RANI's latest filing, from -$483000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $9.4 million in Q4 2025 and bottomed at -$1.7 million in Q1 2026.
  • The 5-year median for Other Working Capital Changes is -$407500.0 (2023), against an average of $338312.5.
  • Across the five-year window, Other Working Capital Changes soared 62.21% in 2024 and plunged 380.81% in 2025, its largest moves.
  • Year by year, Other Working Capital Changes stood at $528000.0 in 2022, then advanced by 1.33% to $535000.0 in 2023, then plunged by 188.97% to -$476000.0 in 2024, then decreased by 1.47% to -$483000.0 in 2025, then rose by 1.24% to -$477000.0 in 2026.
  • Per Business Quant, the three latest RANI Other Working Capital Changes figures stand at -$477000.0 (Q1 2026), -$483000.0 (Q4 2025), and -$472000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,921.77 Bn 66,921.49 Bn -
2 Nanobiotix 1,933.35 Bn 1,933.29 Bn -
3 Akari Therapeutics 1,063.56 Bn 1,063.56 Bn -
4 BeOne Medicines 468.54 Bn 463.75 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.45 Bn 116.20 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.42 Bn 61.67 Bn 3.31 Bn
7 Belite Bio 63.57 Bn 63.57 Bn -
8 Argenx Se 55.83 Bn 50.65 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.75 Bn 34.74 Bn 959.66 Mn
10 Rani Therapeutics Holdings 141.49 Mn 141.49 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -477,000.00
Mar 31, 2026 -477,000.00
Mar 31, 2026 -477,000.00
Dec 31, 2025 -483,000.00
Dec 31, 2025 -483,000.00
Dec 31, 2025 -483,000.00
Sep 30, 2025 -472,000.00
Sep 30, 2025 -472,000.00
Sep 30, 2025 -472,000.00
Jun 30, 2025 -476,000.00
Jun 30, 2025 -476,000.00
Jun 30, 2025 -476,000.00
Mar 31, 2025 -478,000.00
Mar 31, 2025 -478,000.00
Mar 31, 2025 -478,000.00
Dec 31, 2024 -476,000.00
Dec 31, 2024 -476,000.00
Dec 31, 2024 -476,000.00
Sep 30, 2024 -855,000.00
Sep 30, 2024 -855,000.00